MedPath
NMPA Approval

抗骨增生口服液

国药准字Z20025729

July 19, 2022

国药准字Z20025729

Drug Information

抗骨增生口服液

合剂

每支装10ml

中药

July 19, 2022

Company Information

Applicant Company

北京市顺义区林河工业开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.